All media news

Media
Shepparton becoming epicentre for plant-based medicine production  Read More
September 14, 2023
Media
Cannatrek’s Shepparton facility secures GMP accreditation, boosting export opportunities and local jobs  Read More
September 14, 2023
Media
Cannatrek awarded GMP accreditation for Victorian facility  Read More
September 7, 2023
Media
Cannatrek’s Shepparton facility cultivation milestone  Read More
September 7, 2023
Media
Project places Shepparton at the forefront of plant-based medicine production and distribution  Read More
September 7, 2023
Media
Cannatrek’s Shepparton facility achieves GMP accreditation  Read More
September 7, 2023
Media
International pharmaceutical manufacturing accreditation primes Australian plant-based medicine company for accelerated growth and market leadership Read More
September 5, 2023
Government
New Zealand revamps plant-based medicine regulations to boost industry and research  Read More
July 31, 2023
Industry
Ukraine takes major step towards plant-based medicine legalisation  Read More
July 18, 2023
Industry
Germany paves the way for plant-based medicine legalisation with transformative draft bill  Read More
July 10, 2023
Media
Findings from our recent study with CSIRO released Read More
July 1, 2023
Media
How Cannatrek is deploying innovation in Australia’s evolving plant-based medicine market  Read More
May 28, 2023
Media
Cannatrek shortlisted as finalist in Cannabiz Awards  Read More
May 28, 2023
Media
The Cannatrek Foundation launches to provide support for veterans and first responders Read More
April 25, 2023
Media
Australia, Japan and Thailand: The Green Triangle Read More
March 6, 2023
Media
A boost for agriculture jobs and training Read More
March 3, 2023
Media
Creating a corner of the field for the patient Read More
February 26, 2023
Media
Major project status an export booster for Cannatrek’s $160 million Shepparton plant-based medicine production facility Read More
February 14, 2023
Media
Cannatrek secures CBA debt facility for state-of-the-art plant-based medicine supply chain in regional Victoria Read More
July 2, 2022
Media
Cannatrek completes capital raise to fund continued growth Read More
May 13, 2022

Careers

We grow people too.
Check out our current advertised positions.

See full listings

Media
stay informed

We believe everyone has the right to quality healthcare, regardless of circumstances.


We’re committed to making plant-based
medicines affordable and accessible for all.







While research into the efficacy and effects of plant-based medicines, including medicinal cannabis, for certain treatments is increasing, it is currently in its early days. Patients should always talk to a health professional for advice on their unique requirements before making any decisions about treatment options. For the latest, most accurate information on medicinal cannabis, head to the TGA website: https://www.tga.gov.au/medicinal-cannabis-guidance-documents

Address:
PO Box 21 Balaclava 3183 VIC Australia

Contact:
1300 122 662
info@cannatrek.com

Cannatrek acknowledges the Traditional Owners and Custodians of the land on which we work and live, and recognises their continuing connection to land, water and community. We pay our respects to their Elders past, present and emerging.

Investors
Sitemap

Copyright ©2023 Cannatrek

Privacy policy

Terms of service